Literature DB >> 18311517

Intestinal permeability and glucagon-like peptide-2 in children with autism: a controlled pilot study.

Marli A Robertson1, David L Sigalet, Jens J Holst, Jon B Meddings, Julie Wood, Keith A Sharkey.   

Abstract

We measured small intestinal permeability using a lactulose:mannitol sugar permeability test in a group of children with autism, with current or previous gastrointestinal complaints. Secondly, we examined whether children with autism had an abnormal glucagon-like peptide-2 (GLP-2) response to feeding. Results were compared with sibling controls and children without developmental disabilities. We enrolled 14 children with autism, 7 developmentally normal siblings of these children and 8 healthy, developmentally normal, unrelated children. Our study did not detect differences in these measures of gastrointestinal function in a group of children with autism.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18311517     DOI： 10.1007/s10803-007-0482-1

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN： 0162-3257


  37 in total

Review 1.  Endomysial antibody in the diagnosis and management of coeliac disease.

Authors:  M W James; B B Scott
Journal:  Postgrad Med J       Date:  2000-08       Impact factor: 2.401

2.  Frequency of gastrointestinal symptoms in children with autistic spectrum disorders and association with family history of autoimmune disease.

Authors:  Maria Valicenti-McDermott; Kathryn McVicar; Isabelle Rapin; Barry K Wershil; Herbert Cohen; Shlomo Shinnar
Journal:  J Dev Behav Pediatr       Date:  2006-04       Impact factor: 2.225

3.  Intestinal permeability is increased in a proportion of spouses of patients with Crohn's disease.

Authors:  N P Breslin; C Nash; R J Hilsden; N B Hershfield; L M Price; J B Meddings; L R Sutherland
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

4.  Pervasive developmental disorders in preschool children: confirmation of high prevalence.

Authors:  Suniti Chakrabarti; Eric Fombonne
Journal:  Am J Psychiatry       Date:  2005-06       Impact factor: 18.112

Review 5.  Biologic actions and therapeutic potential of the proglucagon-derived peptides.

Authors:  Daniel J Drucker
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2005-11

6.  Prevalence of chronic gastrointestinal symptoms in children with autism and autistic spectrum disorders.

Authors:  Cynthia A Molloy; Patricia Manning-Courtney
Journal:  Autism       Date:  2003-06

7.  Repeatability of the sugar-absorption test, using lactulose and mannitol, for measuring intestinal permeability for sugars.

Authors:  R M van Elburg; J J Uil; F T Kokke; A M Mulder; W G van de Broek; C J Mulder; H S Heymans
Journal:  J Pediatr Gastroenterol Nutr       Date:  1995-02       Impact factor: 2.839

8.  GLP-2 levels in infants with intestinal dysfunction.

Authors:  David L Sigalet; Gary Martin; Jon Meddings; Bolette Hartman; Jens J Holst
Journal:  Pediatr Res       Date:  2004-06-16       Impact factor: 3.756

9.  The prevalence of autism spectrum disorders. Recent evidence and future challenges.

Authors:  Tony Charman
Journal:  Eur Child Adolesc Psychiatry       Date:  2002-12       Impact factor: 4.785

10.  Glucagon-like peptide-2 induces intestinal adaptation in parenterally fed rats with short bowel syndrome.

Authors:  Gary R Martin; Laurie E Wallace; David L Sigalet
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2004-02-12       Impact factor: 4.052
View more
  9 in total

Review 1.  The bowel and beyond: the enteric nervous system in neurological disorders.

Authors:  Meenakshi Rao; Michael D Gershon
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-07-20       Impact factor: 46.802

2.  Can urinary indolylacroylglycine levels be used to determine whether children with autism will benefit from dietary intervention?

Authors:  Julie Wilson; Barry Wright; Sandra Jost; Robert Smith; Helen Pearce; Sally Richardson
Journal:  Pediatr Res       Date:  2016-11-23       Impact factor: 3.756

Review 3.  Food allergy and autism spectrum disorders: is there a link?

Authors:  Harumi Jyonouchi
Journal:  Curr Allergy Asthma Rep       Date:  2009-05       Impact factor: 4.806

4.  A pilot study examining the relationship among Crohn disease activity, glucagon-like peptide-2 signalling and intestinal function in pediatric patients.

Authors:  David L Sigalet; Dragan Kravarusic; Decker Butzner; Bolette Hartmann; Jens J Holst; Jon Meddings
Journal:  Can J Gastroenterol       Date:  2013-10       Impact factor: 3.522

5.  The Gluten-Free/Casein-Free Diet: A Double-Blind Challenge Trial in Children with Autism.

Authors:  Susan L Hyman; Patricia A Stewart; Jennifer Foley; Usa Cain; Robin Peck; Danielle D Morris; Hongyue Wang; Tristram Smith
Journal:  J Autism Dev Disord       Date:  2016-01

Review 6.  Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders.

Authors:  Carlo Catassi; Julio C Bai; Bruno Bonaz; Gerd Bouma; Antonio Calabrò; Antonio Carroccio; Gemma Castillejo; Carolina Ciacci; Fernanda Cristofori; Jernej Dolinsek; Ruggiero Francavilla; Luca Elli; Peter Green; Wolfgang Holtmeier; Peter Koehler; Sibylle Koletzko; Christof Meinhold; David Sanders; Michael Schumann; Detlef Schuppan; Reiner Ullrich; Andreas Vécsei; Umberto Volta; Victor Zevallos; Anna Sapone; Alessio Fasano
Journal:  Nutrients       Date:  2013-09-26       Impact factor: 5.717

Review 7.  Zinc in gut-brain interaction in autism and neurological disorders.

Authors:  Guillermo Vela; Peter Stark; Michael Socha; Ann Katrin Sauer; Simone Hagmeyer; Andreas M Grabrucker
Journal:  Neural Plast       Date:  2015-03-23       Impact factor: 3.599

Review 8.  Effects of Diet, Nutrition, and Exercise in Children With Autism and Autism Spectrum Disorder: A Literature Review.

Authors:  Shriya Doreswamy; Anam Bashir; Jesus E Guarecuco; Simmy Lahori; Ayesha Baig; Lakshmi Rekha Narra; Pinal Patel; Stacey E Heindl
Journal:  Cureus       Date:  2020-12-22

9.  Gluten- and casein-free dietary intervention for autism spectrum conditions.

Authors:  Paul Whiteley; Paul Shattock; Ann-Mari Knivsberg; Anders Seim; Karl L Reichelt; Lynda Todd; Kevin Carr; Malcolm Hooper
Journal:  Front Hum Neurosci       Date:  2013-01-04       Impact factor: 3.169
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.